Adaptyv

Summary active Updated Aug 30, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Lausanne, Switzerland
Founded 2022
Latest Stage Series A
Total Raised €34.35M

Investors

Y Combinator series-a (2026)

Founders

Julian Englert Co-Founder
Daniel Nakhaee-Zadeh Gutierrez Co-Founder

About

Adaptyv is a Lausanne, Switzerland–based biotech startup building an automated wet lab for AI-driven protein design 123. The company synthesises DNA in-house, expresses proteins cell-free, and measures binding using SPR with built-in quality control, all accessible through a web platform or API so AI agents can order their own experiments directly 1. Founded by Julian Englert and Daniel Nakhaee-Zadeh Gutierrez, Adaptyv counts over 100 customers including frontier AI labs, top pharma companies, and AI-native drug discovery startups 13. The company plans to open a second lab and office in London in Q4 2026 12.

Disclaimer: This is a lean profile built from initial round coverage and may be expanded as more information becomes available.

Funding History

Date Round Amount Lead Co-investors
2026-08-26 Series A €34.35M Highland Europe Ace Ventures, ByFounders, Y Combinator 123

The Series A was reported as €34.35M (approximately $40M) by press outlets 12.

What Investors Say

No independently sourced investor quotes available at this time.

What Founders Say

No independently sourced founder quotes available at this time.

Sources


  1. EU-Startups, “Lausanne-based Adaptyv raises €34.35 million Series A to build the automated lab for agentic biology,” August 27, 2026, accessed August 2026. https://www.eu-startups.com/2026/08/lausanne-based-adaptyv-raises-e34-35-million-series-a-to-build-the-automated-lab-for-agentic-biology

  2. Startupticker, “Adaptyv raises $40M to build automated lab for agentic biology,” August 26, 2026, accessed August 2026. https://www.startupticker.ch/en/news/adaptyv-raises-40m-to-build-automated-lab-for-agentic-biology

  3. Dealroom, “Adaptyv raises $40M Series A to automate lab work for AI-designed proteins,” August 2026, accessed August 2026. https://dealroom.co/news/147086-adaptyv-raises-40m-series-a-to-automate-lab-work-for-ai-designed-protein/